Morgan Stanley
NMTR

Morgan Stanley’s 9 Meters Biopharma NMTR Stock Holding History

Morgan Stanley’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,962
Closed -$1.99K – 7824
2023
Q2 		$1.99K Buy
2,962
+380
+15% +$336 ﹤0.01% 7198
2023
Q1 		$3.59K Sell
2,582
-572
-18% -$1.08K ﹤0.01% 7133
2022
Q4 		$3.97K Sell
3,154
-1,980
-39% -$4.51K ﹤0.01% 7208
2022
Q3 		$22K Sell
5,134
-629
-11% -$3.12K ﹤0.01% 6762
2022
Q2 		$29K Buy
5,763
+826
+17% +$7.78K ﹤0.01% 6848
2022
Q1 		$60K Sell
4,937
-925
-16% -$12.6K ﹤0.01% 6627
2021
Q4 		$114K Buy
5,862
+1,364
+30% +$30.5K ﹤0.01% 6360
2021
Q3 		$118K Sell
4,498
-54,115
-92% -$1.28M ﹤0.01% 6280
2021
Q2 		$1.29M Buy
58,613
+56,097
+2,230% +$1.38M ﹤0.01% 4933
2021
Q1 		$59K Buy
2,516
+2,241
+815% +$68.9K ﹤0.01% 6283
2020
Q4 		$5K Buy
+275
New +$4.59K ﹤0.01% 6783
2020
Q2 		– Sell
-50
Closed -$1K – 6784
2020
Q1 		$1K Hold
50
– – ﹤0.01% 6509
2019
Q4 		$1K Sell
50
-3,140
-98% -$52.3K ﹤0.01% 6606
2019
Q3 		$68K Sell
3,190
-438
-12% -$8.85K ﹤0.01% 5582
2019
Q2 		$84K Buy
3,628
+136
+4% +$4.08K ﹤0.01% 5405
2019
Q1 		$135K Sell
3,492
-1,476
-30% -$63.8K ﹤0.01% 5252
2018
Q4 		$229K Buy
4,968
+550
+12% +$40.8K ﹤0.01% 5226
2018
Q3 		$604K Buy
4,418
+1,731
+64% +$297K ﹤0.01% 4887
2018
Q2 		$1.27M Buy
2,687
+2,290
+577% +$843K ﹤0.01% 4452
2018
Q1 		$218K Buy
+397
New +$77.3K ﹤0.01% 5433

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIS
Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
RFA
Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

Morgan Stanley's NMTR Position: Q3 2023 in Review

Morgan Stanley sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 2,962 shares — an estimated $1.99K sold.

Morgan Stanley first reported a position in NMTR in Q1 2018 and held it in 20 quarters. The position peaked at $1.29M in Q2 2021. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • Morgan Stanley reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • Morgan Stanley sold 2,962 9 Meters Biopharma shares in Q3 2023, an estimated $1.99K.
  • Morgan Stanley first reported a position in 9 Meters Biopharma in Q1 2018 and held it in 20 quarters.
  • Morgan Stanley's 9 Meters Biopharma position peaked at $1.29M in Q2 2021.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on Morgan Stanley's 13F filing for Q3 2023, filed 15 Nov 2023.